Publications

Identification of p38 MAPK inhibition as a neuroprotective strategy for combinatorial SMA therapy

 57
Identification of p38 MAPK inhibition as a neuroprotective strategy for combinatorial SMA therapy

Tags:

Previous Article

ERK1/2 signaling targeting in cancer

Next Article

MAPK inhibition to protect against spinal muscular atrophy

Related Posts

Form follows function – structural interplay between DCL1 and pri-miRNAs

Form follows function – structural interplay between DC...

 374

A nucleolar mechanism suppresses organismal proteostasis by modulating TGFβ/ERK signalling

A nucleolar mechanism suppresses organismal proteostasi...

 87

Dnmt1 determines bone length by regulating energy metabolism of growth plate chondrocytes

Dnmt1 determines bone length by regulating energy metab...

 33